ArticlePharmaceuticals (Basel, Switzerland)2025
Variations in Plasma Levels of Orally Administered Ivermectin Could Hamper Its Potential Drug Repositioning: Results of a Bioequivalence Study in Mexican Population.
Ernesto de la Puente et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.